1 |
Rona-Voros, K., and Weydt, P. (2010). The role of PGC- in the pathogenesis of neurodegenerative disorders. Curr. Drug Targets 11, 1262-1269.
DOI
|
2 |
Ross, C.A., and Tabrizi, S.J. (2011). Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 10, 83-98.
DOI
|
3 |
Sampaio-Marques, B., Felgueiras, C., Silva, A., Rodrigues, M., Tenreiro, S., Franssens, V., Reichert, A.S., Outeiro, T.F., Winderickx, J., and Ludovico, P. (2012). SNCA ( -synuclein)-induced toxicity in yeast cells is dependent on sirtuin 2 (Sir2)-mediated mitophagy. Autophagy 8, 1494-1509.
DOI
|
4 |
Satoh, A., Brace, C.S., Rensing, N., Cliften, P., Wozniak, D.F., Herzog, E.D., Yamada, K.A., and Imai, S.I. (2013). Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab. 18, 416-430.
DOI
|
5 |
Shin, J.H., Ko, H.S., Kang, H., Lee, Y., Lee, Y.I., Pletinkova, O., Troconso, J.C., Dawson, V.L., and Dawson, T.M. (2011). PARIS (ZNF746) repression of PGC- contributes to neurodegeneration in Parkinson's disease. Cell 144, 689-702.
DOI
|
6 |
Sinclair, D.A., and Guarente, L. (1997). Extrachromosomal rDNA circles--a cause of aging in yeast. Cell 91, 1033-1042.
DOI
|
7 |
Stotland, A., and Gottlieb, R.A. (2015). Mitochondrial quality control: Easy come, easy go. Biochim. Biophys. Acta 1853, 2802-2811.
DOI
|
8 |
Sugden, M.C., Caton, P.W., and Holness, M.J. (2010). PPAR control: it's SIRTainly as easy as PGC. J. Endocrinol. 204, 93-104.
DOI
|
9 |
Suzuki, M., and Bartlett, J.D. (2014). Sirtuin1 and autophagy protect cells from fluoride-induced cell stress. Biochim. Biophys. Acta 1842, 245-255.
DOI
|
10 |
Tadaishi, M., Miura, S., Kai, Y., Kawasaki, E., Koshinaka, K., Kawanaka, K., Nagata, J., Oishi, Y., and Ezaki, O. (2011). Effect of exercise intensity and AICAR on isoform-specific expressions of murine skeletal muscle PGC- mRNA: a role of -adrenergic receptor activation. Am. J. Physiol. Endocrinol. Metab. 300, E341-E349.
DOI
|
11 |
Tang, B.L. (2006). SIRT1, neuronal cell survival and the insulin/IGF- 1 aging paradox. Neurobiol. Aging 27, 501-505.
DOI
|
12 |
Tang, B.L. (2009). Sirt1's complex roles in neuroprotection. Cell Mol. Neurobiol. 29, 1093-1103.
DOI
|
13 |
Tanner, K.G., Landry, J., Sternglanz, R., and Denu, J.M. (2000). Silent information regulator 2 family of NAD- dependent histone/ protein deacetylases generates a unique product, 1-Oacetyl- ADP-ribose. Proc. Natl. Acad. Sci. USA 97, 14178-14182.
DOI
|
14 |
Tanno, M., Sakamoto, J., Miura, T., Shimamoto, K., and Horio, Y. (2007). Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J. Biol. Chem. 282, 6823-6832.
DOI
|
15 |
Tissenbaum, H.A., and Guarente, L. (2001). Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410, 227-230.
DOI
|
16 |
Tsunemi, T., and La Spada, A.R. (2012). PGC- at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond. Prog Neurobiol. 97, 142-151.
DOI
|
17 |
Um, J.H., Park, S.J., Kang, H., Yang, S., Foretz, M., McBurney, M.W., Kim, M.K., Viollet, B., and Chung, J.H. (2010). AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 59, 554-563.
DOI
|
18 |
Vaziri, H., Dessain, S.K., Ng Eaton, E., Imai, S.I., Frye, R.A., Pandita, T.K., Guarente, L., and Weinberg, R.A. (2001). hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107, 149-159.
DOI
|
19 |
Vaquero, A., Scher, M.B., Lee, D.H., Sutton, A., Cheng, H.L., Alt, F.W., Serrano, L., Sternglanz, R., and Reinberg, D. (2006). SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev. 20, 1256-1261.
DOI
|
20 |
Vaquero, A., Scher, M., Erdjument-Bromage, H., Tempst, P., Serrano, L., and Reinberg, D. (2007). SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation. Nature 450, 440-444.
DOI
|
21 |
Vega, R.B., Horton, J.L., and Kelly, D.P. (2015). Maintaining Ancient Organelles: Mitochondrial Biogenesis and Maturation. Circ. Res. 116, 1820-1834.
DOI
|
22 |
Verdin, E., and Ott, M. (2015). 50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond. Nat. Rev. Mol. Cell Biol. 16, 258-264.
DOI
|
23 |
Webb, A.E., and Brunet, A. (2014). FOXO transcription factors: key regulators of cellular quality control. Trends. Biochem. Sci. 39, 159-169.
DOI
|
24 |
Wood, J.G., Rogina, B., Lavu, S., Howitz, K., Helfand, S.L., Tatar, M., and Sinclair, D. (2004). Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 430, 686-689.
DOI
|
25 |
Yang, X.J., and Seto, E. (2008). The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat. Rev. Mol. Cell Biol. 9, 206-218.
|
26 |
Yeung, F., Hoberg, J.E., Ramsey, C.S., Keller, M.D., Jones, D.R., Frye, R.A., and Mayo, M.W. (2004). Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369-2380.
DOI
|
27 |
Zheng, B., Liao, Z., Locascio, J.J., Lesniak, K.A., Roderick, S.S., Watt, M.L., Eklund, A.C., Zhang-James, Y., Kim, P.D., Hauser, M.A., et al. (2010). PGC- , a potential therapeutic target for early intervention in Parkinson's disease. Sci. Transl. Med. 2, 52ra73.
|
28 |
Yoshii, S.R., and Mizushima, N. (2015). Autophagy machinery in the context of mammalian mitophagy. Biochim. Biophys. Acta 1853, 2797-2801.
DOI
|
29 |
Zhang, Y., Zhang, M., Dong, H., Yong, S., Li, X., Olashaw, N., Kruk, P.A., Cheng, J.Q., Bai, W., Chen, J., et al. (2009). Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene 28, 445-460.
DOI
|
30 |
Zhang, F., Wang, S., Gan, L., Vosler, P.S., Gao, Y., Zigmond, M.J., and Chen, J. (2011). Protective effects and mechanisms of sirtuins in the nervous system. Prog. Neurobiol. 95, 373-395.
DOI
|
31 |
Zong, H., Ren, J.M., Young, L.H., Pypaert, M., Mu, J., Birnbaum, M.J., and Shulman, G.I. (2002). AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. USA 99, 15983-15987.
DOI
|
32 |
Zu, Y., Liu, L., Lee, M.Y.K., Xu, C., Liang, Y., Man, R.Y., Vanhoutte, P.M., and Wang, Y. (2010). SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circ. Res. 106, 1384-1393.
DOI
|
33 |
Barger, P.M., Browning, A.C., Garner, A.N., and Kelly, D.P. (2001). p38 mitogen-activated protein kinase activates peroxisome proliferator- activated receptor alpha: a potential role in the cardiac metabolic stress response. J Biol. Chem. 276, 44495-44501.
DOI
|
34 |
Aquilano, K., Baldelli, S., Pagliei, B., and Ciriolo, M.R. (2012). Extranuclear localization of SIRT1 and PGC- : an insight into possible roles in diseases associated with mitochondrial dysfunction. Curr. Mol. Med. 13, 140-154.
DOI
|
35 |
Austin, S., and St-Pierre, J. (2012). and mitochondrial metabolism-- emerging concepts and relevance in ageing and neurodegenerative disorders. J. Cell Sci. 125, 4963-4971.
DOI
|
36 |
Bai, P., Canto, C., Oudart, H., Brunyanszki, A., Cen, Y., Thomas, C., Yamamoto, H., Huber, A., Kiss, B., Houtkooper, R.H., et al. (2011). PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 13, 461-468.
DOI
|
37 |
Bogenhagen, D.F. (2012). Mitochondrial DNA nucleoid structure. Biochim. Biophys. Acta. 1819, 914-920.
DOI
|
38 |
Brachmann, C.B., Sherman, J.M., Devine, S.E., Cameron, E.E., Pillus, L., and Boeke, J.D. (1995). The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability. Genes Dev. 9, 2888- 2902.
DOI
|
39 |
Brunet, A., Sweeney, L.B., Sturgill, J.F., Chua, K.F., Greer, P.L., Lin, Y., Tran, H., Ross, S.E., Mostoslavsky, R., Cohen, H.Y., Hu, L.S., Cheng, H.L., Jedrychowski, M.P., Gygi, S.P., Sinclair, D.A., Alt, F.W., and Greenberg, M.E. (2004). Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011-2015.
DOI
|
40 |
Ebrahim, A.S., Ko, L.W., and Yen, S.H. (2010). Reduced expression of peroxisome-proliferator activated receptor gamma coactivator- 1alpha enhances alpha-synuclein oligomerization and down regulates AKT/GSK3beta signaling pathway in human neuronal cells that inducibly express alpha-synuclein. Neurosci. Lett. 473, 120-125.
DOI
|
41 |
Eiyama, A., and Okamoto, K. (2015). PINK1/Parkin-mediated mitophagy in mammalian cells. Curr. Opin. Cell Biol. 33, 95-101.
DOI
|
42 |
Fang, E.F., Scheibye-Knudsen, M., Brace, L.E., Kassahun, H., SenGupta, T., Nilsen, H., Mitchell, J.R., Croteau, D.L., and Bohr, V.A. (2014). Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction. Cell 157, 882-896.
DOI
|
43 |
Feige, J.N., Lagouge, M., Canto, C., Strehle, A., Houten, S.M., Milne, J.C., Lambert, P.D., Mataki, C., Elliott, P.J., and Auwerx, J. (2008). Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab. 8, 347-358.
DOI
|
44 |
Ferber, E.C., Peck, B., Delpuech, O., Bell, G.P., East, P., and Schulze, A. (2012). FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression. Cell Death Differ. 19, 968-979.
DOI
|
45 |
Garcia-Roves, P.M., Osler, M.E., Holmstrom, M.H., and Zierath, J.R. (2008). Gain-of-function R225Q mutation in AMP-activated protein kinase gamma3 subunit increases mitochondrial biogenesis in glycolytic skeletal muscle. J. Biol. Chem. 283, 35724-35734.
DOI
|
46 |
Gerhart-Hines, Z., Rodgers, J.T., Bare, O., Lerin, C., Kim, S.H., Mostoslavsky, R., Alt, F.W., Wu, Z., and Puigserver, P. (2007). Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J. 26, 1913-1923.
DOI
|
47 |
Canto, C., and Auwerx, J. (2009). Caloric restriction, SIRT1 and longevity. Trends Endocrinol. Metab. 20, 325-331.
DOI
|
48 |
Burnett, C. Valentini, S., Cabreiro, F., Goss, M., Somogyvari, M., Piper, M.D., Hoddinott, M., Sutphin, G.L., Leko, V., McElwee, J.J., et al. (2011). Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 477, 482-485.
DOI
|
49 |
Byles, V., Chmilewski, L.K., Wang, J., Zhu, L., Forman, L.W., Faller, D.V., and Dai, Y. (2010). Aberrant cytoplasm localization and protein stability of SIRT1 is regulated by PI3K/IGF-1R signaling in human cancer cells. Int. J. Biol. Sci. 6, 599-612.
|
50 |
Campbell, C.T., Kolesar, J.E., and Kaufman, B.A. (2012). Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number. Biochim. Biophys. Acta 1819, 921-929.
DOI
|
51 |
Canto, C., Gerhart-Hines, Z., Feige, J.N., Lagouge, M., Noriega, L., Milne, J.C., Elliott, P.J., Puigserver, P., and Auwerx, J. (2009). AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056-1060.
DOI
|
52 |
Canto, C., Jiang, L.Q., Deshmukh, A.S., Mataki, C., Coste, A., Lagouge, M., Zierath, J.R., and Auwerx, J. (2010). Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 11, 213-219.
DOI
|
53 |
Cheng, H.L., Mostoslavsky, R., Saito, S., Manis, J.P., Gu, Y., Patel, P., Bronson, R., Appella, E., Alt, F.W., and Chua, K.F. (2003). Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc. Natl. Acad. Sci. USA 100, 10794-10799.
DOI
|
54 |
Lan, F., Cacicedo, J.M., Ruderman, N., and Ido, Y. (2008). SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J. Biol. Chem. 283, 27628-27635.
DOI
|
55 |
Kukidome, D., Nishikawa, T., Sonoda, K., Imoto, K., Fujisawa, K., Yano, M., Motoshima, H., Taguchi, T., Matsumura, T., and Araki, E. (2006). Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes 55, 120-127.
DOI
|
56 |
La Spada, A.R. (2012). PPARGC1A/PGC- , TFEB and enhanced proteostasis in Huntington disease: defining regulatory linkages between energy production and protein-organelle quality control. Autophagy 8, 1845-1847.
DOI
|
57 |
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006). Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127, 1109-1122.
DOI
|
58 |
Leick, L., Fentz, J., Bienso, R.S., Knudsen, J.G., Jeppesen, J., Kiens, B., Wojtaszewski, J.F.P., and Pilegaard, H. (2010). PGC- 1{alpha} is required for AICAR-induced expression of GLUT4 and mitochondrial proteins in mouse skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 299, E456-E465.
DOI
|
59 |
Li, X., Monks, B., Ge, Q., and Birnbaum, M.J. (2007). Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator. Nature 447, 1012-1016.
DOI
|
60 |
Lim, J.H., Lee, Y.M., Chun, Y.S., Chen, J., Kim, J.E., and Park, J.W. (2010). Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol. Cell 38, 864- 878.
DOI
|
61 |
McBurney, M.W., Yang, X., Jardine, K., Hixon, M., Boekelheide, K., Webb, J.R., Lansdorp, P.M., and Lemieux, M. (2003). The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. Mol. Cell Biol. 23, 38-54.
DOI
|
62 |
Liu, M., Wilk, S.A., Wang, A., Zhou, L., Wang, R.H., Ogawa, W., Deng, C., Dong, L.Q., and Liu, F. (2010). Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR. J. Biol. Chem. 285, 36387-36394.
DOI
|
63 |
Longo, V.D. (2009). Linking sirtuins, IGF-I signaling, and starvation. Exp. Gerontol. 44, 70-74.
DOI
|
64 |
Luo, J., Nikolaev, A.Y., Imai, S., Chen, D., Su, F., Shiloh, A., Guarente, L., and Gu, W. (2001). Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107, 137-148.
DOI
|
65 |
Meshkini, A., and Yazdanparast, R. (2012). Foxo3a targets mitochondria during guanosine 5'-triphosphate guided erythroid differentiation. Int. J. Biochem. Cell Biol. 44, 1718-1728.
DOI
|
66 |
Michishita, E., Park, J.Y., Burneskis, J.M., Barrett, J.C., and Horikawa, I. (2005). Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol. Biol. Cell. 16, 4623-4635.
DOI
|
67 |
Mishra, P., and Chan, D.C. (2014). Mitochondrial dynamics and inheritance during cell division, development and disease. Nat. Rev. Mol. Cell Biol. 15, 634-646.
DOI
|
68 |
Mitchell, S.J., Martin-Montalvo, A., Mercken, E.M., Palacios, H.H., Ward, T.M., Abulwerdi, G., Minor, R.K., Vlasuk, G.P., Ellis, J.L., Sinclair, D.A., et al. (2014). The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet. Cell Rep. 6, 836-843.
DOI
|
69 |
Mudo, G., Makela, J., Di Liberto, V., Tselykh, T.V., Olivieri, M., Piepponen, P., Eriksson, O., Malkia, A., Bonomo, A., Kairisalo, M., et al. (2012). Transgenic expression and activation of PGC-1 protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease. Cell. Mol. Life Sci. 69, 1153-1165.
DOI
|
70 |
Mouchiroud, L., Houtkooper, R.H., Moullan, N., Katsyuba, E., Ryu, D., Canto, C., Mottis, A., Jo, Y.S., Viswanathan, M., Schoonjans, K., et al. (2013). The NAD(+)/Sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 154, 430-441.
DOI
|
71 |
Mullin, S., and Schapira, A. (2015). The genetics of Parkinson's disease. Br Med. Bull. 114, 39-52.
DOI
|
72 |
Murayama, A., Ohmori, K., Fujimura, A., Minami, H., Yasuzawa- Tanaka, K., Kuroda, T., Oie, S., Daitoku, H., Okuwaki, M., Nagata, K., et al. (2008). Epigenetic control of rDNA loci in response to intracellular energy status. Cell 133, 627-639.
DOI
|
73 |
Nemoto, S., Fergusson, M.M., and Finkel, T. (2005). SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J. Biol. Chem. 280, 16456-16460.
DOI
|
74 |
Ng, F., and Tang, B.L. (2013). Sirtuins' modulation of autophagy. J. Cell. Physiol. 228, 2262-2270.
DOI
|
75 |
Ng, F., Wijaya, L., and Tang, B.L. (2015). SIRT1 in the brainconnections with aging-associated disorders and lifespan. Front. Cell Neurosci. 9, 64.
|
76 |
Nisoli, E., Tonello, C., Cardile, A., Cozzi, V., Bracale, R., Tedesco, L., Falcone, S., Valerio, A., Cantoni, O., Clementi, E., et al. (2005). Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 310, 314-317.
DOI
|
77 |
Pacholec, M., Bleasdale, J.E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R.S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., et al. (2010). SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J. Biol. Chem. 285, 8340- 8351.
DOI
|
78 |
Olmos, Y., Sanchez-Gomez, F.J., Wild, B., Garcia-Quintans, N., Cabezudo, S., Lamas, S., and Monsalve, M. (2013). SirT1 regulation of antioxidant genes is dependent on the formation of a FoxO3a/PGC- complex. Antioxid. Redox Signal. 19, 1507- 1521.
DOI
|
79 |
Ou, X., Lee, M.R., Huang, X., Messina-Graham, S., and Broxmeyer, H.E. (2014). SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells 32, 1183-1194.
DOI
|
80 |
Pacelli, C., De Rasmo, D., Signorile, A., Grattagliano, I., di Tullio, G., D'Orazio, A., Nico, B., Comi, G.P., Ronchi, D., Ferranini, E., et al. (2011). Mitochondrial defect and PGC- dysfunction in parkinassociated familial Parkinson's disease. Biochim. Biophys. Acta 1812, 1041-1053.
DOI
|
81 |
Papandreou, I., Cairns, R.A., Fontana, L., Lim, A.L., and Denko, N.C. (2006). HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3, 187-197.
DOI
|
82 |
Park, S.J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A.L., et al. (2012). Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148, 421-433.
DOI
|
83 |
Reznick, R.M., and Shulman, G.I. (2006). The role of AMP-activated protein kinase in mitochondrial biogenesis. J. Physiol. 574, 33- 39.
DOI
|
84 |
Philp, A., Chen, A., Lan, D., Meyer, G.A., Murphy, A.N., Knapp, A.E., Olfert, I.M., McCurdy, C.E., Marcotte, G.R., Hogan, M.C., et al. (2011). Sirtuin 1 (SIRT1) deacetylase activity is not required for mitochondrial biogenesis or peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) deacetylation following endurance exercise. J. Biol. Chem. 286, 30561-30570.
DOI
|
85 |
Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado De Oliveira, R., Leid, M., McBurney, M.W., and Guarente, L. (2004). Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429, 771-776.
DOI
|
86 |
Price, N.L., Gomes, A.P., Ling, A.J., Duarte, F.V., Martin-Montalvo, A., North, B.J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J.S., et al. (2012). SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 15, 675-690.
DOI
|
87 |
Reznick, R.M., Zong, H., Li, J., Morino, K., Moore, I.K., Yu, H.J., Liu, Z.X., Dong, J., Mustard, K.J., Hawley, S.A., et al. (2007). Agingassociated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metab. 5, 151-156.
DOI
|
88 |
Rodgers, J.T., Lerin, C., Haas, W., Gygi, S.P., Spiegelman, B.M., and Puigserver, P. (2005). Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434, 113-118.
DOI
|
89 |
Rogina, B., and Helfand, S.L. (2004). Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. USA. 101, 15998-16003.
DOI
|
90 |
Ghosh, H.S., McBurney, M., and Robbins, P.D. (2010). SIRT1 negatively regulates the mammalian target of rapamycin. PLoS One 5, e9199.
DOI
|
91 |
Gomes, A.P., Price, N.L., Ling, A.J.Y., Moslehi, J.J., Montgomery, M.K., Rajman, L., White, J.P., Teodoro, J.S., Wrann, C.D., Hubbard, B.P., et al. (2013). Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155, 1624-1638.
DOI
|
92 |
Gregoretti, I.V., Lee, Y.M., and Goodson, H.V. (2004). Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J. Mol. Biol. 338, 17-31.
DOI
|
93 |
Guarente, L. (2011). Sirtuins, aging, and metabolism. Cold Spring Harb. Symp. Quant. Biol. 76, 81-90.
DOI
|
94 |
Gurd, B.J. (2011). Deacetylation of PGC- by SIRT1: importance for skeletal muscle function and exercise-induced mitochondrial biogenesis. Appl. Physiol. Nutr. Metab. 36, 589-597.
DOI
|
95 |
Gurd, B.J., Yoshida, Y., Lally, J., Holloway, G.P., and Bonen, A. (2009). The deacetylase enzyme SIRT1 is not associated with oxidative capacity in rat heart and skeletal muscle and its overexpression reduces mitochondrial biogenesis. J. Physiol. 587, 1817-1828.
DOI
|
96 |
Gurd, B.J., Yoshida, Y., McFarlan, J.T., Holloway, G.P., Moyes, C.D., Heigenhauser, G.J.F., Spriet, L., and Bonen, A. (2011). Nuclear SIRT1 activity, but not protein content, regulates mitochondrial biogenesis in rat and human skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301, R67-R75.
DOI
|
97 |
Haigis, M.C., and Guarente, L.P. (2006). Mammalian sirtuins-- emerging roles in physiology, aging, and calorie restriction. Genes Dev. 20, 2913-2921.
DOI
|
98 |
Han, M.K., Song, E.K., Guo, Y., Ou, X., Mantel, C., and Broxmeyer, H.E. (2008). SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2, 241-251.
DOI
|
99 |
Haigis, M.C., and Sinclair, D.A. (2010). Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 5, 253- 295.
DOI
|
100 |
Hallows, W.C., Lee, S., and Denu, J.M. (2006). Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc. Natl. Acad. Sci. USA 103, 10230-10235.
DOI
|
101 |
Hancock, C.R., Han, D.H., Higashida, K., Kim, S.H., and Holloszy, J.O. (2011). Does calorie restriction induce mitochondrial biogenesis? A reevaluation. FASEB J. 25, 785-791.
DOI
|
102 |
Hardie, D.G. (2011). Sensing of energy and nutrients by AMPactivated protein kinase. Am J. Clin. Nutr. 93, 891S-8916.
DOI
|
103 |
Hathorn, T., Snyder-Keller, A., and Messer, A. (2011). Nicotinamide improves motor deficits and upregulates PGC- and BDNF gene expression in a mouse model of Huntington's disease. Neurobiol. Dis. 41, 43-50.
DOI
|
104 |
Herranz, D., Munoz-Martin, M., Canamero, M., Mulero, F., Martinez- Pastor, B., Fernandez-Capetillo, O., and Serrano, M. (2010). Sirt1 improves healthy ageing and protects from metabolic syndrome- associated cancer. Nat. Commun. 1, 3.
|
105 |
Higashida, K., Kim, S.H., Jung, S.R., Asaka, M., Holloszy, J.O., and Han, D.H. (2013). Effects of resveratrol and SIRT1 on PGC- activity and mitochondrial biogenesis: A reevaluation. PLoS Biol. 11, e1001603.
DOI
|
106 |
Hubbard, B.P., Gomes, A.P., Dai, H., Li, J., Case, A.W., Considine, T., Riera, T.V., Lee, J.E., E, S.Y., Lamming, D.W., et al. (2013). Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science 339, 1216-1219.
DOI
|
107 |
Hong, S., Zhao, B., Lombard, D.B., Fingar, D.C., and Inoki, K. (2014). Cross-talk between sirtuin and mammalian target of rapamycin complex 1 (mTORC1) signaling in the regulation of S6 kinase 1 (S6K1) phosphorylation. J. Biol. Chem. 289, 13132- 13141.
DOI
|
108 |
Hou, X., Xu, S., Maitland-Toolan, K.A., Sato, K., Jiang, B., Ido, Y., Lan, F., Walsh, K., Wierzbicki, M., Verbeuren, T.J., et al. (2008). SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem. 283, 20015-20026.
DOI
|
109 |
Howitz, K.T., Bitterman, K.J., Cohen, H.Y., Lamming, D.W., Lavu, S., Wood, J.G., Zipkin, R.E., Chung, P., Kisielewski, A., Zhang, L.L., et al. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196.
DOI
|
110 |
Jackson, M.D., and Denu, J.M. (2002). Structural identification of 2'- and 3'-O-acetyl-ADP-ribose as novel metabolites derived from the Sir2 family of beta -NAD+-dependent histone/protein deacetylases. J. Biol. Chem. 277, 18535-18544.
DOI
|
111 |
Jacobs, K.M., Pennington, J.D., Bisht, K.S., Aykin-Burns, N., Kim, H.S., Mishra, M., Sun, L., Nguyen, P., Ahn, B.H., Leclerc, J., et al. (2008). SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression. Int. J. Biol. Sci. 4, 291-299.
|
112 |
Jager, S., Handschin, C., St-Pierre, J., and Spiegelman, B.M. (2007). AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. USA 104, 12017-12022.
DOI
|
113 |
Kang, H.T., and Hwang, E.S. (2009). Nicotinamide enhances mitochondria quality through autophagy activation in human cells. Aging Cell 8, 426-438.
DOI
|
114 |
Jang, S.Y., Kang, H.T., and Hwang, E.S. (2012). Nicotinamideinduced mitophagy: event mediated by high NAD+/NADH ratio and SIRT1 protein activation. J. Biol. Chem. 287, 19304-19314.
DOI
|
115 |
Jin, Q., Yan, T., Ge, X., Sun, C., Shi, X., and Zhai, Q. (2007). Cytoplasm- localized SIRT1 enhances apoptosis. J. Cell. Physiol. 213, 88-97.
DOI
|
116 |
Kaeberlein, M., McDonagh, T., Heltweg, B., Hixon, J., Westman, E.A., Caldwell, S.D., Napper, A., Curtis, R., DiStefano, P.S., Fields, S., et al. (2005). Substrate-specific activation of sirtuins by resveratrol. J. Biol. Chem. 280, 17038-17045.
DOI
|
117 |
Kawai, Y., Garduno, L., Theodore, M., Yang, J., and Arinze, I.J. (2011). Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization. J. Biol. Chem. 286, 7629-7640.
DOI
|
118 |
Kim, H., Yang, J., Kim, M.J., Choi, S., Chung, J.R., Kim, J.M., Yoo, Y.H., Chung, J., and Koh, H. (2015). Tumor necrosis factor receptor- associated protein 1 (TRAP1) mutation and TRAP1 inhibitor gamitrinib-triphenylphosphonium (G-TPP) induce a forkhead box O (FOXO)-dependent cell protective signal from mitochondria. J. Biol. Chem. (in press).
|
119 |
Koh, H., Kim, H., Kim, M.J., Park, J., Lee, H.J., and Chung, J. (2012). Silent information regulator 2 (Sir2) and Forkhead box O (FOXO) complement mitochondrial dysfunction and dopaminergic neuron loss in Drosophila PTEN-induced kinase 1 (PINK1) null mutant. J. Biol. Chem. 287, 12750-12758.
DOI
|
120 |
Albani, D., Polito, L., Batelli, S., De Mauro, S., Fracasso, C., Martelli, G., Colombo, L., Manzoni, C., Salmona, M., Caccia, S., et al. (2009). The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alphasynuclein or amyloid-beta (1-42) peptide. J. Neurochem. 110, 1445-1456.
DOI
|
121 |
Amat, R., Planavila, A., Chen, S.L., Iglesias, R., Giralt, M., and Villarroya, F. (2009). SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-gamma Co-activator- 1alpha (PGC-1alpha) gene in skeletal muscle through the PGC- 1alpha autoregulatory loop and interaction with MyoD. J. Biol. Chem. 284, 21872-21880.
DOI
|
122 |
Anderson, R.M., Barger, J.L., Edwards, M.G., Braun, K.H., O'Connor, C.E., Prolla, T.A., and Weindruch, R. (2008). Dynamic regulation of PGC-1alpha localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response. Aging Cell. 7, 101-111.
DOI
|
123 |
Aquilano, K., Vigilanza, P., Baldelli, S., Pagliei, B., Rotilio, G., and Ciriolo, M.R. (2010). Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J. Biol. Chem. 285, 21590-21599.
DOI
|
124 |
Dinkova-Kostova, A.T., Baird, L., Holmstrom, K.M., Meyer, C.J., and Abramov, A.Y. (2015). The spatiotemporal regulation of the Keap1-Nrf2 pathway and its importance in cellular bioenergetics. Biochem. Soc. Trans. 43, 602-610.
DOI
|
125 |
Civitarese, A.E., Carling, S., Heilbronn, L.K., Hulver, M.H., Ukropcova, B., Deutsch, W.A., Smith, S.R., Ravussin, E., and CALERIE Pennington Team (2007). Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 4, e76.
DOI
|
126 |
Cui, L., Jeong, H., Borovecki, F., Parkhurst, C.N., Tanese, N., and Krainc, D. (2006). Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127, 59-69.
DOI
|
127 |
Dasgupta, B., and Milbrandt, J. (2007). Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl. Acad. Sci. USA 104, 7217- 7222.
DOI
|
128 |
Dominy, J.E., Lee, Y., Gerhart-Hines, Z., and Puigserver, P. (2010). Nutrient-dependent regulation of PGC-1alpha's acetylation state and metabolic function through the enzymatic activities of Sirt1/GCN5. Biochim. Biophys. Acta 1804, 1676-1683.
DOI
|
129 |
Donmez, G., Arun, A., Chung, C.Y., McLean, P.J., Lindquist, S., and Guarente, L. (2012). SIRT1 protects against -synuclein aggregation by activating molecular chaperones. J. Neurosci. 32, 124- 132.
DOI
|
130 |
Dumont, M., Stack, C., Elipenahli, C., Jainuddin, S., Launay, N., Gerges, M., Starkova, N., Starkov, A.A., Calingasan, N.Y., Tampellini, D., Pujol, A., and Beal, M.F. (2014). PGC- overexpression exacerbates -amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease. FASEB J. 28, 1745-1755.
DOI
|